New preclinical study finds Niagen® prevents light-induced retinal damage in mice
ChromaDex Corp. has announced new preclinical research published in Investigative Ophthalmology & Visual Science finding Niagen® (patented nicotinamide riboside, or NR) prevented light-induced retinal damage in mice. This research paves the way for future preclinical and clinical studies exploring the relationship … Read More